Will issue joint statement soon, says Serum India CEO after row over Bharat Biotech

Serum Institute of India CEO Adar Poonawala on Tuesday said a joint public statement will be issued soon to clear up any miscommunication with regard to Bharat Biotech.

He tweeted, “I would like to clarify two matters; as there is confusion in the public domain, exports of vaccines are permitted to all countries and a joint public statement clearing up any recent miscommunication with regards to Bharat Biotech will be made.”

The tweet comes following a video press conference by Bharat Biotech chairman Krishna Ella on Monday evening lashing out at his detractors criticising the fast-track granting of emergency use authorisation to the firm’s vaccine Covaxin and statements made by other manufacturers in India.

Meanwhile, Progressive Medicos and Scientists Forum, a national association of doctors and scientists on Tuesday said that they suspected that clearance granted to Covid vaccines by DCGI meant profit and political gains had taken precedence over science.

In a statement, the group said that India was quick to criticise China and Russia for emergency approvals without efficacy data but it failed to exercise diligence when its turn arrived.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

Thank You

Leave a Reply